Live feed07:05:00·809dPRReleasevia QuantisnowHarmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare EpilepsyByQuantisnow·Wall Street's wire, on your screen.HRMY· Harmony Biosciences Holdings Inc.Health Care
